# Metformin Plus Insulin on Non-obese Autoimmune Diabetes

> **NCT03513874** · PHASE4 · UNKNOWN · sponsor: **Second Xiangya Hospital of Central South University** · enrollment: 15 (estimated)

## Conditions studied

- Type 1 Diabetes Mellitus
- Autoimmune Diabetes

## Interventions

- **DRUG:** Metformin
- **DRUG:** Insulin

## Key facts

- **NCT ID:** NCT03513874
- **Lead sponsor:** Second Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-08-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-04-01
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2020-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03513874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03513874, "Metformin Plus Insulin on Non-obese Autoimmune Diabetes". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03513874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*